MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Rob Faulkner
Rob FaulknerREDMILE GROUP

Rob Faulkner

Managing Director at REDMILE GROUP

Investor

Deal Bio

Total Deals6
Valued Deals6
Total Value£ 1.52 B
Avg. Deal Size£ 253 M

Market Context

Sort

30 Mar 2020|United States|Biotechnology
Elevatebio
The Invus Group

Target: ELEVATEBIO LLC

Bidder: THE INVUS GROUP LLC

12 Service Providers

3 Target | 9 Bidder

24 Dealmakers

9 Target | 15 Bidder

£ 137 M

Value

13 Mar 2020|United Kingdom|Pharmaceuticals
Redx Pharma
Redmile Group

Target: REDX PHARMA

Bidder: REDMILE GROUP

10 Service Providers

5 Target | 5 Bidder

20 Dealmakers

9 Target | 11 Bidder

£ 29 M

Value

20 May 2020|United States|Pharmaceuticals
Atea Pharmaceuticals
Ally Bridge Group

Target: ATEA PHARMACEUTICALS INC

Bidder: ALLY BRIDGE GROUP

15 Service Providers

2 Target | 13 Bidder

27 Dealmakers

4 Target | 24 Bidder

£ 175 M

Value

15 Jun 2020|United States|Biotechnology
Shattuck Labs
Hatteras Venture Partners

Target: SHATTUCK LABS

Bidder: HATTERAS VENTURE PARTNERS

12 Service Providers

3 Target | 9 Bidder

15 Dealmakers

4 Target | 11 Bidder

£ 94 M

Value

18 Feb 2021|United States|Semiconductors
QUANTUM-SI
Highcape Capital Acquisition Corp

Target: QUANTUM-SI

Bidder: HIGHCAPE CAPITAL ACQUISITION CORP

16 Service Providers

2 Target | 14 Bidder

37 Dealmakers

6 Target | 32 Bidder

£ 1.05 B

Value

28 Oct 2021|United Kingdom|Biotechnology
Sphere Fluidics
Redmile Group

Target: SPHERE FLUIDICS

Bidder: REDMILE GROUP

4 Service Providers

2 Target | 2 Bidder

5 Dealmakers

3 Target | 2 Bidder

£ 31 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite